INSIGHTS ON CLINICAL TRIAL DESIGN
-
Pharma R&D Annual Review Supplement: New Active Substances
Last year was by some distance the best year ever in terms of new active substances. Explore the 105 new debuts that easily outstrips that of the previous record holder, 2021’s, 97.
-
Avoiding Vaporware – Even More Questions To Ask eClinical Platform Providers
For a platform that aligns with the demands of modern clinical research, delve into these considerations to ensure your choice supports your study’s success.
-
Outlook Good For 7 Drugs Up For Q3 Review
A total of 24 drugs, devices, diagnostics, and deals are expected to progress in the third quarter of 2024, including approval applications for 17 drugs. The estimated overall likelihood of approval is 90% or higher for seven of those drugs, including revumenib for acute myelogenous leukemia and KarXT for schizophrenia.
-
How Smarter Financial Strategies Improve Trial Performance
CROs play a critical role in ensuring the financial and operational success of clinical trials, yet outdated budgets and inefficient payment processes continue to create challenges for sites.
-
Mental Health: 5 Facts About Psychedelics10/16/2024
As mental health issues surge globally, especially following the COVID-19 pandemic, renewed interest in psychedelic drugs is driving research into their potential therapeutic uses.
-
Cell And Gene Therapy For Enhanced CNS And Ocular Delivery In Nonhuman Primates2/20/2025
Gain valuable insights into the cutting-edge approaches shaping the future of gene and cell therapy delivery, ensuring more effective and efficient translation from discovery to clinical application.
-
Balancing Innovation, Ethics, and Operational Excellence in Adaptive Oncology Trials1/30/2025
Experts discuss how to navigate the complexities of adaptive trial designs and how ethics reviews uphold patient safety, ensure informed consent, and provide robust oversight.
-
How Mobile Clinics Advance Diversity In Clinical Research12/4/2025
Mobile clinics reduce participation barriers, enable more inclusive trials, deliver representative data, speed timelines, and advance equity in research.
-
Human-Centered RTSM Design Enhances Data, Safety, And Operations12/5/2025
Uncover how this human-centered approach to RTSM prioritizes user experience (UX) and interface design (UI) to reduce complexity, minimize errors, and improve compliance.
CLINICAL TRIAL DESIGN SOLUTIONS
-
By examining how satisfaction data is gathered, interpreted, and acted upon, we highlight a framework intended to strengthen relationships and enhance service quality.
-
Integrate sensors into your study to evaluate digital endpoints with a comprehensive solution that accelerates drug development, reduces patient sample sizes, cuts costs, and improves patient insights.
-
Whether you need isotopically labelled (14C/SIL) compounds for nonclinical or clinical metabolism studies and the quantification of materials in biological matrices, our expertise provides the necessary labelled materials tailored to support your studies.
-
CSSi is a global, full-service company offering customized services to support recruitment and retention programs around the world.
-
Advarra University is the main hub for all of the training opportunities to help your team and staff feel confident in navigating the technology in their day-to-day operations.